Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
rekombinant human insulinanalog |
Is a |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin human antibody measurement |
Has measured component |
False |
Human insulin |
Inferred relationship |
Some |
|
Human insulin antibody (substance) |
Direct substance |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin human antibody measurement |
Component |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulinanalogprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Human insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human insulin |
Inferred relationship |
Some |
1 |
bivirkning af Humulin insulin |
Causative agent |
False |
Human insulin |
Inferred relationship |
Some |
1 |
Allergy to human insulin |
Causative agent |
False |
Human insulin |
Inferred relationship |
Some |
|
opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin lispro 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin lispro 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin lispro 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart |
Is a |
True |
Human insulin |
Inferred relationship |
Some |
|
insulin aspart 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin aspart 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, suspension, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Human isophane insulin 100units/mL injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, suspension i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk insulin lispro 25/75 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk insulin lispro 25/75 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin lispro 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin human 30% w/v insulin susp isophane recomb 70% injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing insulin aspart (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing insulin lispro (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Human isophane insulin 100units/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Product containing insulin aspart and insulin aspart protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
semisyntetisk human insulin |
Is a |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin zink med forlænget virkning 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 30/70 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 30/70 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 25/75 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
insulin aspart (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, opløsning, fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 15/85 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane human 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 20/80 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 40/60 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin soluble human 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin soluble human 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin soluble human 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
blandet humant insulin zink suspension, 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|
Insulin isophane biphasic human 15/85 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin |
Inferred relationship |
Some |
|